Vice President, Head of Transactions and Partnering

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Vice President, Head of Transactions and Partnering is a senior leader within the Corporate Development organization and will play a key role in the evaluation, structuring, negotiation, and execution of strategic business development transactions that support Revolution Medicines’ corporate and portfolio objectives. Reporting to the Head of Corp Development, this individual is a leader and principal negotiator across licensing, collaboration, co-development, alliance, option, platform, and other business development agreements.

The role partners closely with executive leadership and stakeholders across Research, Development, Commercial, Finance, Legal, Intellectual Property, and Executive Management to shape strategy and advance high-priority opportunities from initial assessment through execution.

• Lead transaction activities, advancing prioritized opportunities from evaluation through execution while ensuring resources are focused on the highest-value opportunities.
• Serve as the senior transaction lead for the most complex and strategically significant business development opportunities, while developing and empowering team members to lead transactions with increasing scope and independence.
• Structure, negotiate, and execute a broad range of transactions, including licensing, collaboration, co-development, alliance, option, platform, and other strategic agreements.
• Lead transaction processes from initial engagement through confidentiality agreements, term sheet development, definitive agreement negotiation, and transaction closing.
• Develop creative transaction structures that appropriately balance strategic objectives, economics, operational considerations, and risk allocation.
• Identify transaction risks and develop practical solutions that facilitate successful deal execution while protecting the company’s interests.

• Serve as Revolution Medicines' senior negotiator for strategic business development transactions and establish a consistent, high-quality approach to negotiation across the transactions team.
• Partner closely with finance and legal/transaction counsel to develop transaction structures, review and negotiate definitive agreements, and drive successful deal execution.
• Collaborate with FP&A, commercial, competitive intelligence, business development team members to evaluate transaction economics, valuation analyses, and investment considerations.
• Lead negotiations involving scientific, clinical, commercial, intellectual property, operational, and financial elements of complex transactions.
• Develop and execute negotiation strategies that maximize value creation while preserving long-term partnership success.

• Lead and oversee cross-functional transaction teams, aligning scientific, clinical, commercial, financial, intellectual property, and legal stakeholders…